
Loading, please wait...

Loading, please wait...

A recent suspected Ebola case in Bengaluru has tested negative, bringing immense relief to health authorities and the public alike. The 28-year-old Ugandan national, who recently travelled from an Ebola-affected region, isolated herself after exhibiting mild symptoms like body ache. Fortunately, laboratory analysis has ruled out the infection. Consequently, the Union Health Ministry confirmed that India remains free of the virus during the ongoing global alert.
The patient arrived at Kempegowda International Airport from Uganda on May 23. During initial airport screening, airport health officials noticed signs of fatigue, prompting close monitoring. Later, she checked into a hotel but soon developed a mild body ache. In response, health authorities immediately shifted her in an ambulance to the state-run Epidemic Diseases Hospital in Indiranagar.
Clinicians collected her blood samples on May 25 and sent them to the National Institute of Virology (NIV) in Pune. Health officials closely monitored her condition while awaiting the diagnostic results. On May 27, the health ministry announced that her tests were negative for Ebola. Nevertheless, as a standard precautionary measure, clinical teams will conduct a repeat test to ensure absolute safety.
The global medical community is currently on high alert. Specifically, the WHO declared this outbreak a Public Health Emergency of International Concern (PHEIC) on May 17, 2026. This declaration followed a rapid rise in cases across the Democratic Republic of Congo (DRC) and Uganda. The rare Bundibugyo ebolavirus strain drives the current epidemic. Significantly, this species carries a case fatality rate ranging from 25% to 50%.
Unlike the Zaire strain, there are currently no approved vaccines or specific therapeutics for the Bundibugyo strain. Therefore, early supportive care and immediate isolation remain the cornerstones of clinical management.
In response to the African outbreak, the Karnataka Health Department has proactively intensified screening measures. Consequently, authorities have advised all travellers returning from affected countries to undergo strict health monitoring and self-observation for 21 days. Furthermore, the department instructs individuals to report immediately to the nearest health facility if they develop any symptoms.
Additionally, the state government has designated specific hospitals to handle potential cases. For instance, the Rajiv Gandhi Institute of Chest Diseases (RGICD) in Bengaluru serves as the primary isolation centre. Meanwhile, the Epidemic Diseases Hospital in Indiranagar functions as the designated quarantine and treatment facility. In Mangaluru, Wenlock District Hospital and Srinivas Port Hospital have also prepared dedicated isolation units.
Ebola virus disease symptoms usually appear suddenly after an incubation period of two to 21 days. Initially, infected individuals experience flu-like symptoms such as sudden fever, extreme fatigue, muscle pain, headache, and sore throat. As the disease progresses, patients may develop vomiting, diarrhoea, abdominal pain, rash, and impaired kidney or liver function.
Importantly, bleeding symptoms, such as bleeding from the gums, nose, or gastrointestinal tract, usually manifest in later stages. However, bleeding is not always an early or universal symptom. Healthcare providers must remain vigilant, taking detailed travel histories from patients presenting with unexplained febrile illness. Early supportive hydration and symptomatic treatment significantly improve survival rates.
Q1: Did the suspected Ebola case in Bengaluru test positive?
No, the health ministry confirmed that the 28-year-old Ugandan national isolated in Bengaluru tested negative for Ebola virus disease. Currently, India has no confirmed cases of Ebola.
Q2: What are the main symptoms of Ebola virus disease?
Common symptoms include sudden fever, muscle pain, headache, sore throat, extreme fatigue, vomiting, and diarrhoea. In severe cases, patients may also experience internal and external bleeding.
Q3: What quarantine guidelines has the Karnataka government issued?
The Karnataka Health Department advises all individuals returning from Ebola-affected countries to undergo health monitoring and self-observation for 21 days. They must report any symptoms to the nearest healthcare facility immediately.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A Ugandan woman isolated in Bengaluru with a suspected Ebola case has tested negative. The Health Ministry confirms no active Ebola cases in India....
4 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today